Trupanion (TRUP) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Trupanion (NASDAQ: TRUP):

• 8/13/2025 – Trupanion was upgraded by analysts at Cantor Fitzgerald to a “hold” rating.
• 8/12/2025 – Trupanion is now covered by analysts at Cantor Fitzgerald. They set a “neutral” rating and a $47.00 price target on the stock.
• 8/8/2025 – Trupanion had its price target raised by analysts at Piper Sandler from $62.00 to $67.00. They now have an “overweight” rating on the stock.
• 8/8/2025 – Trupanion had its price target raised by analysts at Stifel Nicolaus from $41.00 to $45.00. They now have a “hold” rating on the stock.
• 7/3/2025 – Trupanion had its price target raised by analysts at Piper Sandler from $52.00 to $62.00. They now have an “overweight” rating on the stock.

Insider Buying and Selling

In other news, CFO Fawwad Qureshi sold 2,534 shares of the firm’s stock in a transaction on Thursday, May 29th. The stock was sold at an average price of $48.31, for a total value of $122,417.54. Following the transaction, the chief financial officer directly owned 3,545 shares in the company, valued at $171,258.95. This trade represents a 41.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO John R. Gallagher sold 4,000 shares of the firm’s stock in a transaction on Thursday, May 29th. The stock was sold at an average price of $47.90, for a total value of $191,600.00. Following the completion of the transaction, the chief operating officer owned 26,966 shares in the company, valued at approximately $1,291,671.40. This trade represents a 12.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 7,562 shares of company stock valued at $361,430. 5.42% of the stock is owned by corporate insiders.

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.